Skip to main content
. 2015 Nov 20;5:16975. doi: 10.1038/srep16975

Figure 4. SIFα potentiates the therapeutic effect of Gemcitabin (GEM).

Figure 4

Pancreatic cancer cells ASPC (A) and CFPAC1 (B) were transfected with interferon lentiviruses in the presence of the low dose of GEM. Cell growth was measured by sulforhodamine B (SRB)-assay. All data shown are mean ± SD from three independent. *p < 0.05 as compared with controls and with the wild type IFNα group.